Oct 2018 Reports
Title | Published | Price |
---|---|---|
2018 Fibronectin Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Fibronectin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
2018 Warfarin Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Warfarin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
2018 Rivaroxaban Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Rivaroxaban testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
2018 Fluindione Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Fluindione testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
2018 Edoxaban Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Edoxaban testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
2018 Dabigatran Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Dabigatran testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
2018 Betrixaban Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Betrixaban testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
2018 Argatroban Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Argatroban testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
2018 Apixaban Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Apixaban testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
2018 Ceruloplasmin Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Ceruloplasmin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
2018 Transferrin Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Transferrin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
2018 Myoglobin Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Myoglobin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
2018 Lactic Acid Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Lactic Acid testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
2018 Cholinesterase Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Cholinesterase testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
2018 Calcitonin Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
2018 Beta-Hydroxybutyrate Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Beta-Hydroxybutyrate testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. ... |
Oct 2018 | $ 950 |
2018 Apolipoprotein-B Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Apolipoprotein B testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
2018 Apolipoprotein-A1 Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of Apolipoprotein-A1 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
... |
Oct 2018 | $ 950 |
The Operators must be innovative with their pricing models for LPWABy Analysys Mason
"LPWA pricing requires a different approach to IoT pricing; operators are exploring new pricing models to maximise revenue while creating value for enterprises."
Low ARPC and increasing competition could result in an unsus... |
Oct 2018 | $ 1499 |
2018 C4 Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of C4 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
Geo... |
Oct 2018 | $ 950 |
2018 C3 Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsBy Venture Planning Group
This new report from VPGMarketResearch provides analysis of C3 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
Geo... |
Oct 2018 | $ 950 |
Argentina - Telecoms, Mobile and Broadband - Statistics and AnalysesBy Paul Budde Communication
Overview
This report provides a comprehensive overview of trends and developments in Argentina’s telecommunications market. The report analyses the fixed-line, mobile and broadband sectors. Subjects include:
 ... |
Oct 2018 | $ 1150 |
Costa Rica - Telecoms, Mobile and Broadband- Statistics and AnalysesBy Paul Budde Communication
Executive summaryCosta Rica sees consolidation in the cable telecom sectorCosta Rica’s liberalised telecom sector has seen substantial growth in all sectors in recent years. Although the state-owned operator ICE remains the... |
Oct 2018 | $ 750 |
Slovakia - Telecoms, Mobile and Broadband - Statistics and AnalysesBy Paul Budde Communication
Overview
This report provides a comprehensive overview of trends and developments in Slovakia’s telecommunications market. The report analyses the fixed-line, mobile and broadband sectors. Subjects include:
... |
Oct 2018 | $ 1150 |
Netherlands - Telecoms, Mobile and Broadband - Statistics and AnalysesBy Paul Budde Communication
Overview
This report provides a comprehensive overview of trends and developments in the Netherlands’ telecommunications market. The report analyses the fixed-line, mobile and broadband sectors. Subjects include:
... |
Oct 2018 | $ 1150 |